ID
33138
Description
ADVANCED PROSTATE CANCER DATA COLLECTION Version 2.3.1 Revised: April 10th, 2017 International Consortium for Health Outcomes Measurement (ICHOM), Source: http://www.ichom.org/ Conditions: All patients with advanced prostate cancer, either having metastatic disease or biochemical recurrence progressing after salvage treatment or ineligible for salvage treatment. Patients with biochemical recurrence treated with salvage therapy are referred to the localized prostate cancer set. Treatment Approaches: Hormonal Therapy | Chemotherapy | Immunotherapy | Radiopharmaceuticals | Radiation | Interventions for Complications of Local Progression This form contains clinical and administrative variables. To be assessed 1 year post (initial) treatment and annually for life from then on. Questionnaires used in this standard set: Expanded Prostate Cancer Index Composite (EPIC-26): The EPIC-26 is free for all health care organizations, and a license is not needed. The scoring guide may be found at http://www.med.umich.edu/urology/research/EPIC/EPIC-26-Scoring-1.2007.pdf ; Wei J, Dunn R, Litwin M, Sandler H, and Sanda M. "Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer", Urology. 56: 899-905, 2000. For registries choosing to implement the EPIC‐CP rather than the EPIC‐26, we recommend using the same variable IDs as the corresponding EPIC‐26 questions. This means that only questions 2, 3, 4a, 4b, 4d, 4e, 5, 6e, 6b, 7, 8b, 9, 12, 13a, 13c, and 13d of the EPIC-26 are administered. Utilization of Sexual Medications/Devices: The Utilization of Sexual Medications/Devices is free for all health care organizations, and a license is not needed (according to ICHOM). Refer to http://dx.doi.org/10.1016/j.urology.2006.01.077 for more information European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): For use of the EORTC QLQ-C30 a license is needed, therefore the questions will not be part of this version of the standard set. (eortc.be) The following paper has been published about development of this standard set: Morgans AK, van Bommel ACM, Stowell C, Abrahm JL, Basch E, Bekelman JE, et al. Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach. Eur Urol. 2015 Nov;68(5):891–8. For the standard set ICHOM has been supported by the Movember Foundation.
Link
Keywords
Versions (2)
- 11/29/18 11/29/18 - Sarah Riepenhausen
- 4/30/20 4/30/20 - Sarah Riepenhausen
Copyright Holder
ICHOM
Uploaded on
November 29, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
ICHOM Advanced Prostate Cancer
Follow-Up Clinical Form
- StudyEvent: ODM
Description
Treatment Variables
Alias
- UMLS CUI-1
- C0087111
Description
INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Single answer
Data type
integer
Alias
- UMLS CUI [1]
- C0279492
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on Androgen Deprivation Therapy (ADTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0279492
- UMLS CUI [1,2]
- C0808070
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on Androgen Deprivation Therapy (ADTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0279492
- UMLS CUI [1,2]
- C0806020
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on Androgen Deprivation Therapy (ADTX), and no end date is entered (ADTXSTOPDATE) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Single answer
Data type
integer
Alias
- UMLS CUI [1,1]
- C0279492
- UMLS CUI [1,2]
- C0549178
Description
INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Single answer
Data type
integer
Alias
- UMLS CUI [1]
- C0279025
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on hormonal therapy (HORMONTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0279025
- UMLS CUI [1,2]
- C0808070
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on hormonal therapy (HORMONTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0279025
- UMLS CUI [1,2]
- C0806020
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on hormonal therapy (HORMONTX), and no end date is entered (HORMONTXSTOPDATE) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Single Answer
Data type
integer
Alias
- UMLS CUI [1,1]
- C0279025
- UMLS CUI [1,2]
- C0549178
Description
INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Single Answer
Data type
integer
Alias
- UMLS CUI [1]
- C0392920
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on chemotherapy (CHEMOTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C1302181
- UMLS CUI [1,2]
- C3173309
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on chemotherapy (CHEMOTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C1302181
- UMLS CUI [1,2]
- C0806020
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on chemotherapy (CHEMOTX), and no end date is entered (CHEMOTXSTOPDATE) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Single Answer
Data type
integer
Alias
- UMLS CUI [1,1]
- C0549178
- UMLS CUI [1,2]
- C0392920
Description
INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Single Answer
Data type
integer
Alias
- UMLS CUI [1]
- C0021083
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on immunotherapy (IMMUNOTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0021083
- UMLS CUI [1,2]
- C0808070
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on immunotherapy (IMMUNOTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0021083
- UMLS CUI [1,2]
- C0806020
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on immunotherapy (IMMUNOTX), and no end date is entered (IMMUNOTXSTOPDATE) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Single Answer
Data type
integer
Alias
- UMLS CUI [1,1]
- C0021083
- UMLS CUI [1,2]
- C0549178
Description
INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Single Answer
Data type
integer
Alias
- UMLS CUI [1]
- C0182638
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on radiopharmaceuticals (RADIOPHARM) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0182638
- UMLS CUI [1,2]
- C3173309
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on radiopharmaceuticals (RADIOPHARM) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0182638
- UMLS CUI [1,2]
- C1531784
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on radiotherapy (RADIOTX), and no end date is entered (RADIOTXSTOPDATE) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Single Answer
Data type
integer
Alias
- UMLS CUI [1,1]
- C0182638
- UMLS CUI [1,2]
- C0549178
Description
Could be one of the following procedures: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Multiple answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0184661
- UMLS CUI [1,2]
- C0178874
- UMLS CUI [1,3]
- C1947913
- UMLS CUI [2]
- C0040771
Description
Could be one of the following procedures: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Multiple answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0184661
- UMLS CUI [1,2]
- C0178874
- UMLS CUI [1,3]
- C1947913
- UMLS CUI [2]
- C0183518
Description
Could be one of the following procedures: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Multiple answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0184661
- UMLS CUI [1,2]
- C0178874
- UMLS CUI [1,3]
- C1947913
- UMLS CUI [2]
- C0564457
Description
Could be one of the following procedures: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Multiple answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0184661
- UMLS CUI [1,2]
- C0178874
- UMLS CUI [1,3]
- C1947913
- UMLS CUI [2]
- C0150798
Description
Could be one of the following procedures: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Multiple answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0184661
- UMLS CUI [1,2]
- C0178874
- UMLS CUI [1,3]
- C1947913
- UMLS CUI [2]
- C0179804
- UMLS CUI [3]
- C0473154
Description
INCLUSION CRITERIA: All patients, If answered 'TURP' on interventions for complications due to local progression (LOCPROGTX_1) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0040771
- UMLS CUI [1,2]
- C0011008
Description
INCLUSION CRITERIA: All patients, If answered 'ureteral stent' on interventions for complications due to local progression (LOCPROGTX_2) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0183518
- UMLS CUI [1,2]
- C0011008
Description
INCLUSION CRITERIA: All patients, If answered 'percutaneous nephrostomy tube' on interventions for complications due to local progression (LOCPROGTX_3) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0564457
- UMLS CUI [1,2]
- C0011008
Description
INCLUSION CRITERIA: All patients, If answered 'suprapubic catheter placement' on interventions for complications due to local progression (LOCPROGTX_4) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0150798
- UMLS CUI [1,2]
- C0011008
Description
INCLUSION CRITERIA: All patients, If answered 'chronic foley catheter / self intermittent catheterization' on interventions for complications due to local progression (LOCPROGTX_5) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0179804
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [2,1]
- C0473154
- UMLS CUI [2,2]
- C0011008
Description
INCLUSION CRITERIA: All patients TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Single Answer
Data type
integer
Alias
- UMLS CUI [1]
- C0012544
- UMLS CUI [2]
- C1690432
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on bisphosphonates or denosumab (BISPHOSTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0012544
- UMLS CUI [1,2]
- C0808070
- UMLS CUI [2,1]
- C1690432
- UMLS CUI [2,2]
- C0808070
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on bisphosphonates or denosumab (BISPHOSTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0012544
- UMLS CUI [1,2]
- C0806020
- UMLS CUI [2,1]
- C1690432
- UMLS CUI [2,2]
- C0806020
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on bisphosphonates or denosumab (BISPHOSTX), and no end date is entered (BISPHOSTXSTOPDATE) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Single Answer
Data type
integer
Alias
- UMLS CUI [1,1]
- C0012544
- UMLS CUI [1,2]
- C0549178
- UMLS CUI [2,1]
- C1690432
- UMLS CUI [2,2]
- C0549178
Description
Acute Complications of Treatment
Alias
- UMLS CUI-1
- C0087111
- UMLS CUI-2
- C0009566
Description
A CTCAE v 4 grace III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications INCLUSION CRITERIA: Patients with systemic therapy, If answered 'yes' on chemotherapy, immunotherapy or hormonaltherapy (CHEMOTX or IMMUNOTX or HORMONTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Multiple answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1298908
- UMLS CUI [1,2]
- C0009566
- UMLS CUI [1,3]
- C1515119
- UMLS CUI [1,4]
- C1516728
Description
A CTCAE v 4 grace III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications INCLUSION CRITERIA: Patients with systemic therapy, If answered 'yes' on chemotherapy, immunotherapy or hormonaltherapy (CHEMOTX or IMMUNOTX or HORMONTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Multiple answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0009566
- UMLS CUI [1,2]
- C1515119
- UMLS CUI [1,3]
- C1516728
- UMLS CUI [1,4]
- C0010828
Description
A CTCAE v 4 grace III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications INCLUSION CRITERIA: Patients with systemic therapy, If answered 'yes' on chemotherapy, immunotherapy or hormonaltherapy (CHEMOTX or IMMUNOTX or HORMONTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Multiple answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0009566
- UMLS CUI [1,2]
- C1515119
- UMLS CUI [1,3]
- C1516728
- UMLS CUI [1,4]
- C3714514
Description
A CTCAE v 4 grace III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications INCLUSION CRITERIA: Patients with systemic therapy, If answered 'yes' on chemotherapy, immunotherapy or hormonaltherapy (CHEMOTX or IMMUNOTX or HORMONTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Multiple answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0009566
- UMLS CUI [1,2]
- C1515119
- UMLS CUI [1,3]
- C1516728
- UMLS CUI [1,4]
- C0521362
- UMLS CUI [1,5]
- C0013221
Description
A CTCAE v 4 grace III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications INCLUSION CRITERIA: Patients with systemic therapy, If answered 'yes' on chemotherapy, immunotherapy or hormonaltherapy (CHEMOTX or IMMUNOTX or HORMONTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Multiple answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0009566
- UMLS CUI [1,2]
- C1515119
- UMLS CUI [1,3]
- C1516728
- UMLS CUI [1,4]
- C0442874
Description
A CTCAE v 4 grace III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications INCLUSION CRITERIA: Patients with systemic therapy, If answered 'yes' on chemotherapy, immunotherapy or hormonaltherapy (CHEMOTX or IMMUNOTX or HORMONTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Multiple answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0009566
- UMLS CUI [1,2]
- C1515119
- UMLS CUI [1,3]
- C1516728
- UMLS CUI [1,4]
- C0007226
- UMLS CUI [1,5]
- C0013221
Description
A CTCAE v 4 grace III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications INCLUSION CRITERIA: Patients with systemic therapy, If answered 'yes' on chemotherapy, immunotherapy or hormonaltherapy (CHEMOTX or IMMUNOTX or HORMONTX) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Multiple answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0009566
- UMLS CUI [1,3]
- C1515119
- UMLS CUI [1,4]
- C1516728
Description
INCLUSION CRITERIA: Patients with systemic therapy, If answered 'Other' on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS_888) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Free Text RESPONSE OPTIONS: CTCAE grade III-IV complication due to systemic therapy (excluding ADT)
Data type
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0009566
- UMLS CUI [1,3]
- C1515119
- UMLS CUI [1,4]
- C1516728
Description
INCLUSION CRITERIA: Patients with systemic therapy, If answered Cytopenias on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS_1) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0010828
- UMLS CUI [1,2]
- C0011008
Description
INCLUSION CRITERIA: Patients with systemic therapy, If answered Infection on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS_2) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0009450
- UMLS CUI [1,2]
- C2316983
Description
INCLUSION CRITERIA: Patients with systemic therapy, If answered Vomiting, diarrhea, constipation, other GI toxicity on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS_3) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0521362
- UMLS CUI [1,2]
- C0013221
- UMLS CUI [1,3]
- C0011008
Description
INCLUSION CRITERIA: Patients with systemic therapy, If answered Neuropathy on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS_4) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0442874
- UMLS CUI [1,2]
- C0011008
Description
INCLUSION CRITERIA: Patients with systemic therapy, If answered Cardiovascular toxicity on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS_ 5) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0007226
- UMLS CUI [1,2]
- C0013221
- UMLS CUI [1,3]
- C2316983
Description
INCLUSION CRITERIA: Patients with systemic therapy, If answered Other on CTCAE grade III-IV complications due to systemic therapy (excluding ADT) (COMPLSYS_888) TIMING: Update at least annually REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0009566
- UMLS CUI [1,2]
- C0011008
Description
Degree of Health
Alias
- UMLS CUI-1
- C0018759
Description
ECOG / WHO scale: - PS = 0 normal activity level; - PS = 1 restricted with strenuous activity, but can do light activity; - PS = 2 active >/= 50% of day; - PS = 3 spends >50% of day in chair or bed; - PS = 4 totally confined to bed INCLUSION CRITERIA: All patients TIMING: Baseline, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Clinical TYPE: Single Answer
Data type
integer
Alias
- UMLS CUI [1,1]
- C1520224
- UMLS CUI [1,2]
- C1298650
Description
Survival and disease control
Alias
- UMLS CUI-1
- C1148433
- UMLS CUI-2
- C0920467
Description
procedures for local progression: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization INCLUSION CRITERIA: All patients, If answered 'yes' on procedures needed for local progression (LOCPROGTX) TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Multiple Answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0184661
- UMLS CUI [1,2]
- C0449258
- UMLS CUI [1,3]
- C0549184
Description
procedures for local progression: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization INCLUSION CRITERIA: All patients, If answered 'yes' on procedures needed for local progression (LOCPROGTX) TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Multiple Answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0184661
- UMLS CUI [1,2]
- C0449258
- UMLS CUI [1,3]
- C0040771
Description
procedures for local progression: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization INCLUSION CRITERIA: All patients, If answered 'yes' on procedures needed for local progression (LOCPROGTX) TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Multiple Answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0184661
- UMLS CUI [1,2]
- C0449258
- UMLS CUI [1,3]
- C0183518
Description
procedures for local progression: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization INCLUSION CRITERIA: All patients, If answered 'yes' on procedures needed for local progression (LOCPROGTX) TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Multiple Answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0184661
- UMLS CUI [1,2]
- C0449258
- UMLS CUI [1,3]
- C0564457
Description
procedures for local progression: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization INCLUSION CRITERIA: All patients, If answered 'yes' on procedures needed for local progression (LOCPROGTX) TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Multiple Answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0184661
- UMLS CUI [1,2]
- C0449258
- UMLS CUI [1,3]
- C0150798
Description
procedures for local progression: - TURP (transurethral resection of the prostate) - Ureteral stent - Percutaneous nephrostomy tube - Suprapubic catheter placement - Chronic foley catheter / self intermittent catheterization INCLUSION CRITERIA: All patients, If answered 'yes' on procedures needed for local progression (LOCPROGTX) TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Multiple Answer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0184661
- UMLS CUI [1,2]
- C0449258
- UMLS CUI [1,3]
- C0179804
- UMLS CUI [2,1]
- C0184661
- UMLS CUI [2,2]
- C0449258
- UMLS CUI [2,3]
- C0473154
Description
INCLUSION CRITERIA: All patients TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Single Answer
Data type
integer
Alias
- UMLS CUI [1,1]
- C0242656
- UMLS CUI [1,2]
- C0153690
- UMLS CUI [1,3]
- C0231220
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on symptomatic skeletal related event (SSRE) TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life, (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C0153690
- UMLS CUI [1,2]
- C0231220
- UMLS CUI [1,3]
- C0011008
Description
INCLUSION CRITERIA: Patients without known metastasis TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Single Answer
Data type
integer
Alias
- UMLS CUI [1,1]
- C0242656
- UMLS CUI [1,2]
- C2939420
Description
INCLUSION CRITERIA: Patients without known metastasis, If answered 'yes' on development of metastasis (METADEV) TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C2316983
- UMLS CUI [1,2]
- C0027627
Description
Castration-resistant disease is defined as two successive PSA rises at least one week apart, or the development or progression of radiographically proven metastatic lesions, in the setting of castrate levels of testosterone (<50 ng/mL) INCLUSION CRITERIA: Patients that are not yet castration resistant TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Single answer
Data type
integer
Alias
- UMLS CUI [1,1]
- C0242656
- UMLS CUI [1,2]
- C3658267
Description
INCLUSION CRITERIA: Patients that are not yet castration resistant, If answered 'yes' on development of castration-resistant disease (CRPCDATE) TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Clinical TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1,1]
- C3658267
- UMLS CUI [1,2]
- C2316983
Description
INCLUSION CRITERIA: All patients TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Administrative data (Death registry) TYPE: Single answer
Data type
integer
Alias
- UMLS CUI [1]
- C0011065
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on overall survival (OVERALLSURV) TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Administrative data (Death registry) TYPE: Date by DD/MM/YYYY
Data type
date
Measurement units
- DD/MM/YYYY
Alias
- UMLS CUI [1]
- C1148348
Description
INCLUSION CRITERIA: All patients, If answered 'yes' on overall survival (OVERALLSURV) TIMING: 1 year post initiation of treatment, Tracked ongoing annually for life (when hospital is able to track this ongoing) REPORTING SOURCE: Administrative data (Death registry) TYPE: Single answer
Data type
integer
Alias
- UMLS CUI [1,1]
- C0007465
- UMLS CUI [1,2]
- C0596130
- UMLS CUI [1,3]
- C0600139
Similar models
Follow-Up Clinical Form
- StudyEvent: ODM
C1442488 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C3173309 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C3173309 (UMLS CUI [1,2])
C1531784 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
(Comment:en)
C0178874 (UMLS CUI [1,2])
C1947913 (UMLS CUI [1,3])
C0040771 (UMLS CUI [2])
C0178874 (UMLS CUI [1,2])
C1947913 (UMLS CUI [1,3])
C0183518 (UMLS CUI [2])
C0178874 (UMLS CUI [1,2])
C1947913 (UMLS CUI [1,3])
C0564457 (UMLS CUI [2])
C0178874 (UMLS CUI [1,2])
C1947913 (UMLS CUI [1,3])
C0150798 (UMLS CUI [2])
C0178874 (UMLS CUI [1,2])
C1947913 (UMLS CUI [1,3])
C0179804 (UMLS CUI [2])
C0473154 (UMLS CUI [3])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0473154 (UMLS CUI [2,1])
C0011008 (UMLS CUI [2,2])
C1690432 (UMLS CUI [2])
(Comment:en)
(Comment:en)
(Comment:en)
C0808070 (UMLS CUI [1,2])
C1690432 (UMLS CUI [2,1])
C0808070 (UMLS CUI [2,2])
C0806020 (UMLS CUI [1,2])
C1690432 (UMLS CUI [2,1])
C0806020 (UMLS CUI [2,2])
C0549178 (UMLS CUI [1,2])
C1690432 (UMLS CUI [2,1])
C0549178 (UMLS CUI [2,2])
(Comment:en)
C0009566 (UMLS CUI-2)
C0009566 (UMLS CUI [1,2])
C1515119 (UMLS CUI [1,3])
C1516728 (UMLS CUI [1,4])
C1515119 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
C0010828 (UMLS CUI [1,4])
C1515119 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
C3714514 (UMLS CUI [1,4])
C1515119 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
C0521362 (UMLS CUI [1,4])
C0013221 (UMLS CUI [1,5])
C1515119 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
C0442874 (UMLS CUI [1,4])
C1515119 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
C0007226 (UMLS CUI [1,4])
C0013221 (UMLS CUI [1,5])
C0009566 (UMLS CUI [1,2])
C1515119 (UMLS CUI [1,3])
C1516728 (UMLS CUI [1,4])
C0009566 (UMLS CUI [1,2])
C1515119 (UMLS CUI [1,3])
C1516728 (UMLS CUI [1,4])
C0011008 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,2])
C0013221 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C0013221 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C1298650 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C1520224 (UMLS CUI-2)
(Comment:en)
C0920467 (UMLS CUI-2)
C0449258 (UMLS CUI [1,2])
C0549184 (UMLS CUI [1,3])
C0449258 (UMLS CUI [1,2])
C0040771 (UMLS CUI [1,3])
C0449258 (UMLS CUI [1,2])
C0183518 (UMLS CUI [1,3])
C0449258 (UMLS CUI [1,2])
C0564457 (UMLS CUI [1,3])
C0449258 (UMLS CUI [1,2])
C0150798 (UMLS CUI [1,3])
C0449258 (UMLS CUI [1,2])
C0179804 (UMLS CUI [1,3])
C0184661 (UMLS CUI [2,1])
C0449258 (UMLS CUI [2,2])
C0473154 (UMLS CUI [2,3])
C0153690 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,3])
(Comment:en)
(Comment:en)
C0231220 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C2939420 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
C0027627 (UMLS CUI [1,2])
C3658267 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
C2316983 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
C0596130 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
(Comment:en)
(Comment:en)
(Comment:en)